Hyoscini butylbromidum
Buscopan and Buscopan Rx are different trade names for the same medicine.
This medicine should always be taken exactly as described in the patient leaflet or as directed by your doctor or pharmacist.
Hyoscine butylbromide, the active substance of Buscopan, is an antispasmodic.
Antispasmodics reduce spasms of the smooth muscles of the internal organs of the abdominal cavity -
in the digestive tract, bile ducts, urinary system, and female reproductive tract, which relieves pain.
They are used to relieve colic pain, i.e., abdominal pain originating from the aforementioned internal organs, whose intensity increases and (or) decreases and is difficult to determine their exact location.
Buscopan can be used in conditions of smooth muscle spasms of the digestive tract (in functional disorders of the digestive tract, painful stomach spasms, intestinal colic, irritable bowel syndrome), in conditions of spasms and dyskinesia of the bile ducts (in functional disorders of the bile ducts, acute pain in the bile ducts, biliary colic), in conditions of spasms in the urogenital system (in painful menstruation, renal colic, spasms associated with kidney stones).
You should be particularly careful in the following situations:
If you have or have had any of the above symptoms or diseases, you should not take Buscopan without consulting your doctor. To determine the cause of your symptoms, your doctor will prescribe the necessary diagnostic tests.
You should stop taking Buscopan and contact your doctor:
You should tell your doctor or pharmacist about all the medicines you are taking now or have taken recently, as well as any medicines you plan to take.
Before taking Buscopan, you should consult your doctor if you are taking the following medicines:
You should also inform your doctor about taking metoclopramide (used to treat vomiting, nausea, or gastrointestinal disorders), as it may weaken the effect of Buscopan and metoclopramide.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor or pharmacist before taking this medicine.
It is recommended to avoid taking Buscopan during pregnancy and breastfeeding.
No studies have been conducted on the effect of the medicine on the ability to drive and use machines. There are no recommendations for taking Buscopan and driving or using machines.
One chewable tablet contains approximately 41.2 mg of sucrose, which corresponds to 411.8 mg of sucrose in the case of the maximum recommended daily dose. If you have previously been diagnosed with intolerance to some sugars, you should consult your doctor before taking the medicine.
This medicine should always be taken exactly as described in the patient leaflet or as directed by your doctor or pharmacist. If you have any doubts, you should consult your doctor or pharmacist.
Recommended dose:
unless your doctor has prescribed otherwise:
children from 6 to 12 years old: 3 times a day, 1 tablet,
adults and children over 12 years old: 3 to 5 times a day, 1 or 2 tablets.
Tablets should be swallowed whole, with a drink.
You should not take Buscopan for more than 3 days without consulting your doctor. If you need to take Buscopan continuously or for a longer period, you should consult your doctor to determine the cause of your symptoms.
In children over 6 years old, Buscopan can be used only with the consent of a doctor.
In children under 6 years old, Buscopan is not recommended due to the high content of the active substance.
If you have taken a higher dose of Buscopan than recommended or if a child under 12 years old has taken the medicine, you should immediately consult your doctor.
The following symptoms may occur: dry mouth, skin redness, difficulty urinating, rapid heartbeat, and vision disturbances.
If you miss a dose, you should take it as soon as you remember, but you should not take a double dose to make up for the missed dose. The next dose should be taken at the usual time.
Buscopan should be taken only when needed and its use should be stopped after the symptoms have disappeared.
If you have any further doubts about taking this medicine, you should consult your doctor or pharmacist.
Like all medicines, Buscopan can cause side effects, although not everybody gets them.
Many of the side effects listed below are due to the anticholinergic effect of the medicine.
They are usually mild and transient.
In addition, the following side effects have been reported:
rapid heartbeat, dry mouth, decreased sweating, skin reactions (hives, itching).
urinary retention.
anaphylactic shock (a sudden and severe allergic reaction characterized by difficulty breathing, circulatory collapse, and sudden swelling), anaphylactic reactions with episodes of respiratory disorders, skin reactions (rash, redness), and other hypersensitivity reactions.
If you experience any side effects, including any possible side effects not listed in the leaflet, you should tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
tel.: + 48 (22) 49 21 301
fax: + 48 (22) 49 21 309
website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Store in a temperature below 30°C. Store in the original packaging to protect from light.
Do not use Buscopan after the expiry date stated on the packaging. The expiry date refers to the last day of the specified month.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Buscopan is a chewable tablet.
Packaging: PVC/Al blister in a cardboard box.
Pack size: 14 chewable tablets.
To obtain more detailed information, you should contact the marketing authorization holder or the parallel importer.
Opella Healthcare France SAS, T/A Sanofi
82 Avenue Raspail
94250 Gentilly, France
Istituto De Angeli S.r.l.
Località Prulli n. 103/c, 50066 Reggello (FI), Italy
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Irish authorization number: PA23180/022/001
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.